Intrauterine growth restriction is associated with decreased fetal insulin secretion and β-cell mass. Insulin has autocrine actions that enhance insulin secretion and β-cell growth, but this has not been demonstrated in the normally growing fetus. We tested the hypothesis that chronic fetal hyperinsulinemia, with euglycemia, increases GSIS and β-cell mass in the ovine fetus. Singleton ovine fetuses at 125.6±0.5 days gestation (term=148) were intravenously infused with insulin (INS, HumulinR, n=8) to produce high physiological insulin concentrations and glucose to maintain euglycemia, or saline (SAL, n=9) for 6-10 days. Fetal arterial pH, oxygen content, glucose, insulin, cortisol, and norepinephrine concentrations were measured. On the final day, fetal GSIS was measured using a square-wave fetal hyperglycemic clamp. The pancreas was fixed for histological analysis. In four additional INS animals, GSIS was measured with and without concurrent pharmacologic adrenergic blockade. Glucose concentrations were similar (18.21±1.85 INS vs. 20.21±1.31 SAL, mg/dL). Oxygen content was lower (2.53±0.25 vs. 3.60±0.11 SAL, mmol/L, p<0.005) and norepinephrine higher (1159±115 INS vs. 553±155 SAL, pg/mL, p<0.01) in INS fetuses. Fetal arterial pH and cortisol were not different. GSIS was present in the SAL group (228% increase from baseline, p<0.05) but absent in the INS group (12% increase). Neither insulin-positive area (2.01±0.21 INS vs. 2.14±0.22 SAL, %) nor β-cell mass (53. 16±5.19 INS vs. 62.34±10.99 SAL, mg) increased in the INS group. Pharmacologic adrenergic blockade restored GSIS in the INS fetuses (117% increase from baseline, p<0.05). Contrary to our hypothesis, chronic fetal insulin infusion decreased fetal oxygen and increased norepinephrine concentrations. β-cell mass was not increased. Pharmacologic adrenergic blockade demonstrated that increased norepinephrine concentrations were responsible for inhibiting GSIS. Increased adrenergic signaling in the β-cell mediates decreased GSIS in conditions characterized by fetal hypoxemia. (NIH R01 DK088139 and K08 HD060688) 1-2. ChroniC Fetal hyperinsulinemia Fails to aCtivate p70 and s6 in sheep skeletal musCle S Bourque 1 , L Brown 1 , S Andrews 2 , S Thorn 1 , W Hay Jr. 1 , and P Rozance 1 Department of 1 Pediatrics and 2 OB/GYN, University of Colorado, Aurora, CO, USA Insulin is necessary for normal fetal growth. However, chronic experimental fetal hyperinsulinemia does not increase growth trajectory beyond normal. The mechanisms responsible for this paradox are unknown. The mTOR signaling pathway is central for regulating fetal growth, protein synthesis, and is activated by acute insulin stimulation; making this a pathway to study. Our objective was to determine if chronic fetal hyperinsulinemia would activate the mTOR pathway in fetal sheep skeletal muscle. Singleton sheep fetuses were infused with continuous intravenous insulin and glucose to maintain euglycemic hyperinsulinemia (INS n=7) or saline (SAL n=8) for 7-9 days. Fetal glucose, amino acids, insulin, norepinephrine, cortisol, IGF-1, pH, lactate, CO2, and O2 were measured. Biopsy of the biceps femoris hindlimb muscle was obtained under study conditions at 134 days (term 148 days). Muscle proteins were prepared and total and phosphorylated p70S6K, 4E-BP1, ribosomal protein S6 (rpS6), and actin were measured by western blotting. Insulin concentrations were 150% higher in the INS group compared to SAL (P<0.001). INS fetuses became hypoxemic and hypoaminoacidemic, but were not acidotic or hypercortisolemic. IGF-1 and norepinephrine concentrations increased 60% and 120%, respectively, in the INS group (P<0.05). There was no effect of insulin on total fetal and individual hindlimb muscle weights. There was 20% less p70S6K in the INS group (p<0.005), but no difference in the ratio of phosphorylated to total p70S6K or the ratio of phosphorylated to total rpS6. The ratio of phosphorylated to total 4E-BP1 was increased 115% in the INS group (p<0.005), but total 4E-BP1 did not change. Chronic fetal hyperinsulinemia increased the phosphorylation of 4E-BP1 but failed to increase phosphorylated p70S6K or rpS6 which may be responsible for the lack of enhanced muscle growth in the presence of chronic fetal hyperinsulinemia. We speculate that this is due to hypoxemia, hypercatecholinemia, and/or hypoaminoacidemia inhibiting mTOR signaling to P70S6K.
1
Heart Research Center, 2 Department of Physiology and Pharmacology, 3 Knight Cardiovascular Institute, 4 Vollum Institute, Oregon Health & Science University, Portland, OR, USA, 5 Portland Veterans Affairs Medical Center, Portland, OR, USA Maturation of fetal cardiomyocytes involves transition from a proliferating to a terminally differentiated non-proliferating state. Ovine fetal cardiomyocytes begin the maturation process after 100 days gestational age (dGA) such that at term (145dGA) ~60% of cardiomyocytes become binucleated. Rising near term thyroid hormone (T3) levels inhibit proliferation and drive myocyte maturation opposing the stimulation of proliferation by insulin-like growth factor-1 (IGF-1). However, the degree to which intracellular signaling patterns change with myocyte maturation when exposed to these hormones is unknown. We hypothesized that T3 and IGF-1 could activate extracellular regulatory kinase (ERK) and AKT signaling proteins similarly between 100 and 135dGA. Cardiomyocytes were enzymatically isolated from non-instrumented, control fetal sheep (n=11/ age, Ovis aries; mixed western breed) at 102 ± 3dGA and 135 ± 1dGA. Proliferation by BrdU uptake (10μM) was performed in the presence of T3 (0.37, 1.5nM), IGF-1 (1μg/ml) and pathway inhibitors (U0126 10μM, LY294002 10μM, Rapamycin 10nM). Western blot and immunohistochemistry were used to determine phosphorylation of ERK, AKT and p70S6K. IGF-1 stimulated proliferation at both ages; the addition of T3 suppressed mitotic activity to near basal levels (~50% reduction in 100dGA and ~75% reduction in 135dGA; p<0.001). IGF-1 and T3 independently stimulated phosphorylation of ERK, AKT, and p70S6K at both ages. In 135dGA cells, the combination of IGF-1 and T3 increased activation of ERK and AKT two-fold with the opposite being true in 100dGA cardiomyocytes. This was partially explained using immunohistochemical analysis: in most (~75%) 135dGA cardiomyocytes, both mono-and binucleated cells phosphorylated ERK and AKT when but only a small percentage were activated in the younger cells.
1-6. elevated norepinephrine proteCts From Greater loss oF β-Cell mass in intrauterine Growth restriCted ovine Fetuses
M Davis, A Macko, M Anderson, and S Limesand The University of Arizona, Tucson, AZ, USA Intrauterine growth restriction (IUGR) is associated with β-cell dysfunction and lower β-cell mass. IUGR fetuses with placental insufficiency are hypoglycemic and hypoxic. In response to these characteristics, norepinephrine is released from adrenal chromaffin cells, which is the sole fetal source for elevated plasma norepinephrine concentrations. Our objective was to determine the effect of chronic norepinephrine exposure on pancreatic endocrine cell area in near-term IUGR fetuses. The pancreas was collected following in vivo measurements from singleton fetuses at 134 days gestational age (term 150 days) for the following treatment groups: control and IUGR fetuses with either a sham or adrenal demedullation (AD) surgical procedure at 98 days. Immunofluorescent staining for pancreatic hormones was performed, and positive areas were measured and expressed as a percent of total pancreas area. As a result of hypoxemia, plasma norepinephrine concentrations were 4-fold greater (P<0.05) in sham IUGR fetuses compared to controls and AD IUGR fetuses, which were not different. Fetal weight was less (P<0.05) for sham and AD IUGR fetuses (1.58±0.3 kg and 2.4±0.4 kg) compared to sham and AD controls (3.2±0.1 kg and 3.2±0.2 kg). Fetal weight was greater (P<0.05) in AD IUGR than sham IUGR fetuses. Insulin positive area for sham control, AD control, sham IUGR, and AD IUGR fetuses were 2.15±0.20%, 1.78±0.26%, 1.53±0.15%, and 0.82±0.22%, respectively. In AD IUGR fetuses, insulin and glucagon positive areas were lower (P<0.05) than other treatment groups, although sham IUGR fetuses were also lower than controls. Lower β-cell areas in AD IUGR fetuses compared to sham IUGR fetuses indicates that norepinephrine to some extent protects β-cells from adverse conditions in placental insufficiency-induced IUGR. (Supported by R01-DK084842) 1-7. ovine Fetal renal development impaCted By multiple Fetuses and uterine spaCe restriCtion KM Meyer-Gesch, MY Sun, SE Blohowiak, R Magness, PJ Kling Departments of Pediatrics/Obstetrics & Gynecology Neonatal/Perinatal Research Laboratories, University of Wisconsin, Madison, WI and Nova Southeastern University College of Osteopathic Medicine, USA Intrauterine growth restriction (IUGR) from uteroplacental dysfunction causes impaired nephrogenesis and ultimately hypertension. It is unknown whether IUGR caused by impaired placental space seen in uterine anomalies and/or multifetal gestation also impairs nephrogenesis. It was hypothesized that limited uterine space causes fetoplacental metabolic adaptations that preserve a viable but compromised fetus with maladaptive renal development and function. Fetal renal development and metabolic status was studied in an ovine uterine space restriction (USR) model of limited space for placental formation and IUGR by combining unilateral horn surgical ligation with multifetal gestation.
Reduced placental attachment sites and placental weight per fetus defined USR versus control nonrestricted (NSR) fetuses (Meyer, et al 2010) . USR fetuses exhibited evidence for decreased plasma volume, with higher hematocrit and plasma albumin at GD120 (p<0.05). At GD130, USR developed IUGR, lower blood pO2 and oxygen content, and higher fetal osmolarity, BUN and creatinine (p<0.05 for all), but not higher plasma erythropoietin levels. In all fetuses, kidney weight relative to fetal weight was not constant, but inversely related to both fetal weight and fetal plasma creatinine levels (p<0.05 for both). Glomerular generations were directly related to cortical depth and inversely related to fetal plasma creatinine levels (p<0.05 for both). At GD130, kidney weights in USR fetuses were smaller, with decreased cortical depths and glomerular generations, with hyperplastic maculae densa (p<0.05 for all). Insufficient space for placental implantation negatively impacted fetal oxygenation, and kidney growth and development. USR-induced insufficiency in fetal renal excretory function was accompanied by an immature endocrine renal erythropoietin response to hypoxemia and a structurally immature nephrogenic zone with altered maculae densa. Using this model of limited placental development as is seen in multifetal gestation and/or uterine anomalies, we are poised to further investigate fetal renal adaptations responsible for programming of adult disease. (NIH HL49210, HD 38843, HL 087144) Maternal uterine artery adenovirus VEGF (Ad.VEGF-A165) gene therapy has been shown to increase pre-and early postnatal growth velocity in an overnourished adolescent ovine model of fetal growth restriction. Herein our objective was to investigate the effect of prenatal Ad.VEGF on fetal and postnatal intestinal mRNA expression of angiogenic factors and their receptors (n=18 genes). In Exp. 1, first parity ewe lamb recipients were offered a control (CON; n=12) or high (H; n=45, 2 x CON) quantity of the same diet after singleton embryo transfer. At 89±1.5 d of gestation overnourished H-ewes were randomly allocated to receive 1 of 3 injections into both uterine arteries: a) Ad.VEGF-A165 (5 × 1011 particles; n=17); b) control Ad vector containing the β-galactosidase reporter gene, Ad.LacZ (n=14); c) saline (n=14). CON received saline. In Exp. 2, overnourished ewes received no injection (n=6), Ad.VEGF-A165 (n=16) or saline (n=15) as described above. Ewes lambed normally at 141±0.4 d gestation and offspring were raised until weaning. Fetal (d 130) and postnatal (d 84) intestinal tissues were harvested and mRNA expression relative to 18s determined. In Exp. 1, no differences (P≥0.16) were observed in mRNA expression. In Exp. 2, maternal Ad.VEGF-A165 increased (P≤0.04) mRNA expression of FLT1, KDR, NRP1, FGF2R, TIE2, NOS3, and sGC, and tended (P≤0.10) to increase ANG1, ANG2, NRP2, FGF2, and HIF1A. Thus the previously reported benefits of this prenatal therapy on birth weight and early postnatal growth were mirrored by increased expression of a cadre of angiogenic genes. These may in turn influence intestinal vascularity and thereby absorptive capacity and nutrient uptake. (Funded by the Wellcome Trust UK, Scottish Government, and AFRI Grant 2012-67016-19453 from USDA-NIFA). 1-9. vitamin d attenuates lunG injury and improves survival in inFant rats aFter antenatal endotoxin exposure EM Mandell, GJ Seedorf, J Gien, SH Abman Pediatric Heart Lung Center, Department of Pediatrics, University of Colorado, School of Medicine, Aurora, CO Chorioamnionitis contributes to the pathogenesis of BPD. Vitamin D (Vit D) has immunomodulatory and anti-inflammatory properties, but whether Vit D can improve neonatal survival, preserve lung vascular and alveolar growth and prevent endothelial injury after exposure to antenatal inflammation is unknown. This study was designed to determine whether Vit D treatment could improve survival and preserve lung growth after antenatal exposure to endotoxin (ETX). Fetal rats were exposed to ETX (10μg), ETX + Vit D (1ng/ml), or saline via intra-amniotic (IA) injection and delivered two days later. Newborn pups exposed to IA ETX received daily injections of Vit D or saline for 2 weeks. To assess lung development, radial alveolar counts (RAC) were assessed at 14d. Fetal sheep pulmonary artery endothelial cells (PAEC) were assessed for growth and tube formation following treatment with Vit D (100-400nM) or ETX (1ng/ml) + Vit D. Growth of alveolar type II (AT II) cells treated with Vit D(100nm) or with ETX (10ng/ml) + Vit D was assessed. Prenatal Vit D treatment improved survival in rat pups exposed to IA ETX when compared to ETX exposure alone (100% vs. 60%; p<0.001) at DOL 14. In comparison to rats exposed to IA ETX, pups who also received either prenatal or postnatal Vit D showed improved RAC at 14 days by 54% (p <0.05). In control PAEC, Vit D increased cell growth and tube formation by 64 and 44% (p<0.001), respectively. ETX decreased PAEC growth and tube formation by 57% and 53% compared to controls (p<0.05), while co-treatment with Vit D preserved PAEC growth and tube formation (p<0.001). In addition, Vit D increased ATII cell growth by 26% (p<0.001) and attenuated ETX induced growth suppression by 73% (p<0.001). Vit D improved survival and enhanced lung structure after antenatal ETX exposure in vivo, and prevented ETX -induced PAEC and AT II cell dysfunction in vitro. Center for Nutrition and Pregnancy, Animal Sciences Department, North Dakota State University, Fargo; 2 Population Health and Reproduction Department, University of California-Davis The enzyme 5α-reductase converts progesterone to 5α-dihydroprogesterone, a precursor to neurosteroids that suppress the fetal hypothalamic-pituitary-adrenal axis (HPAA). The effects of maternal dietary intake and melatonin treatment on fetal hypothalamic 5α-reductase expression were examined. Primiparous ewes carrying singletons were housed at constant temperature (14 °C) and 12:12-h light:dark (lights off at 19:00). On day 50 of gestation, ewes were assigned randomly in a 2 × 2 factorial to melatonin supplementation (0 or 5 mg) and maternal intake (100 or 60% of NRC requirements), resulting in four melatonin × dietary intake groups (n=6-8/group). The pelleted diet contained 15.8% crude protein and 2.66 Mcal/kg. Melatonin was delivered once daily at 14:00 by top-dressing the pellets (100 g) with melatonin in ethanol (5mg/kg). Maternal jugular serum was obtained at 23:00 on days 44 (baseline), 84, and 124 of gestation. At slaughter on d130,
we obtained umbilical arterial serum, and fetal hypothalamic samples were frozen for qPCR. As previously reported (Lemley et al, Am J Physiol 302:R454-R467, 2012), maternal jugular melatonin concentrations were similar on d44 and on days 84 and 124 were unaffected by dietary intake but elevated (P<0.001) 2-fold in melatonin-treated compared with untreated ewes. Similarly, on day 130 umbilical arterial melatonin concentrations were unaffected by dietary intake but elevated (P<0.001) 50% in melatonin-treated compared with untreated ewes. For fetal hypothalamic mRNA expression of 5α-reductase type 1, there was a main effect (P<0.02) of melatonin (expression relative to 18S rRNA: 1.55±0.19 for melatonin-treated vs. 0.78±0.22 for untreated) but no effect of dietary intake and no melatonin-diet interaction. There was no effect of melatonin treatment or dietary intake on fetal hypothalamic mRNA expression of 5α-reductase type 2. These data suggest that diurnal changes in activity of the fetal HPAA may result from melatonin-induced changes in expression of 5α-reductase. mRNA. (Supported partly by a Lalor Foundation grant to COL) 1-11. Fetal hypoGlyCemia induCes Fetal hepatiC GluCose output S Sekar, P Rozance, L Brown, W Hay, R Wilkening, S Thorn University of Colorado School of Medicine, Aurora, CO, USA This study was designed to measure fetal hepatic glucose production in response to hypoglycemia and determine the role of carbon substrates and hormones. Late gestation fetal sheep (n=5) had catheters placed in the abdominal aorta, umbilical vein, and left hepatic vein to simultaneously measure umbilical and hepatic substrate fluxes. Fetal glucose, lactate, pyruvate, amino acids (AA), hormones, and oxygen concentrations, and umbilical and hepatic blood flow rates were measured and umbilical and hepatic substrate and oxygen flux rates were calculated. Metabolic studies were done prior to (d0) and after (d1 and d5) induction of fetal hypoglycemia by a maternal insulin infusion. Fetal glucose concentrations and glucose uptake rates were 50% lower on d1 and d5 compared to d0. Net hepatic glucose output (d0: -14.6 µmol/min/100g liver) increased on d1 (1.5 µmol/min/100g liver) and d5 (16.1 µmol/min/100g liver). Hepatic lactate and pyruvate uptake rates were unchanged yet total hepatic AA uptake increased 50% on d1 compared to d0 and d5. Interestingly, on d0 the liver released glutamate and this was reduced by 33% on d1 and 56% on d5. Total hepatic carbon uptake and hepatic oxygen uptake increased on d1 compared to d0 and d5, suggesting an acute increase in hepatic metabolism. Total fetal carbon uptake, however, was reduced by 16% on d1 and 39% on d5 and became less than fetal oxygen uptake demonstrating decreased nutrient supply for growth and oxidative metabolism. Fetal insulin concentrations were 50% lower, and glucagon and cortisol concentrations were increased >50% on d5. The insulin:glucagon ratio correlated with hepatic glucose output (r2=0.568). Using hepatic catheterization, we demonstrate fetal hepatic glucose output in response to hypoglycemia. Increased hepatic provision of carbon from AA and glycogenolysis likely contribute to hepatic glucose output on d1. By d5, we speculate that hormonal changes favoring gluconeogenesis re-directed hepatic carbon output from glutamate to glucose. These findings are important for understanding the development of fetal hepatic glucose output in response to hypoglycemia. (NIH-T32-HD007186, NIH-K01-DK090199)
1-12. ovine ClaviCular Brown adipose tissue has a diFFerent oriGin
From the perirenal depot that is indiCative oF musCle related lineaGe ME Symonds, M Pope, M Birtwistle, V Perry and H Budge Academic Division of Child Health, School of Medicine, University of Nottingham, Nottingham, NG7 2UH, United Kingdom Multiple evidence from human studies indicates that the primary sites for brown adipose tissue in humans are the bilateral clavicular depots. In this study we aimed to identify an analogous region in the young sheep and whether it contained microRNA (MIR) specific to muscle or adipose tissue. This was compared with perirenal-abdominal adipose tissue which represents the major fat depot in young sheep. Four triplet-bearing mothers were entered into the study and a randomly selected triplet euthanased at 1, 7 or 28 days of age for adipose tissue sampling. Gene expression for target genes was determined by quantitative reverse transcriptase polymerase chain reaction. MIR 206 was highly abundant in skeletal muscle and was also detectable in BAT sampled from the clavicular but not perirenal depot at all sampling ages. This was despite an age related decline in UCP1 and related genes, whereas gene expression of RIP140 increased with age. Our study suggests a different cell lineage in clavicular adipose tissue compared with other BAT depots in the young sheep. Despite showing beige characteristics with increasing age, retention of some muscular origins may mean it is more response to environmental challenges aimed at promoting BAT function. The young sheep, therefore, provides a novel model for examining the developmental process of adipose transformation in early life.
1-13. evidenCe For inCreased Cori CyCle aCtivity in iuGr Fetus
S Thorn, P Rozance, J Friedman, W Hay, L Brown University of Colorado School of Medicine, Aurora, CO, USA We previously showed that acute hyperinsulinemia fails to suppress the adaptive increase in hepatic glucose production and gluconeogenic gene expression in IUGR fetal sheep. IUGR fetuses also had normal to higher basal and insulin-stimulated glucose utilization rates, higher lactate, and lower oxygen concentrations, despite similar oxygen consumption rates. We hypothesize that skeletal muscle glucose utilization and subsequent lactate production is increased to fuel hepatic glucose production, defining an active Cori cycle in the IUGR fetus. Whole-body glucose metabolic studies were performed in late gestation control (CON, n=6) and IUGR fetuses (n=8) under basal and hyperinsulinemic-isoglycemic (3h) conditions. Liver and skeletal muscle samples were collected during hyperinsulinemia (n=11 CON, 12 IUGR) and from animals receiving a saline infusion (basal, n=6 CON, 7 IUGR) for gene expression analysis. Basal glucose oxidation rate was similar in CON and IUGR fetuses and increased by 50% during hyperinsulinemia. However, the fraction of glucose oxidized by the IUGR fetuses was 10% lower compared to CON fetuses during basal and hyperinsulinemia, suggesting decreased complete oxidation of glucose. IUGR fetuses also had lower lactate uptake rates from the placenta, indicating increased fetal production. IUGR muscle had higher basal expression of glycolytic genes, including phosphofructokinase (PFK1, 2-fold) and pyruvate kinase (PKM, 50%), yet higher pyruvate dehydrogenase (PDH) kinase 4 (PDK4, 10-fold, an inhibitor of PDH) and lower isocitrate dehydrogenase (IDH1, 50%), suggesting decreased glucose oxidation. IUGR liver had increased phosphoenolpyrvuvate carboxykinase, (PCK1, 30-fold), pyruvate carboxylase (PC, 2-fold), and PDK4 (5-fold) with decreased pyruvate kinase (PK, 50%) and IDH1 (50%) expression, supporting increased gluconeogenesis, increased lactate utilization, and decreased glucose oxidation. Hyperinsulinemia had little effect on these genes. These molecular and metabolic flux data support an active Cori cycle in the IUGR fetus. We speculate that increased lactate production from muscle resulting from increased glycolysis stimulates hepatic lactate utilization, a process which may play an important role for increased glucose production in the IUGR fetal liver. (NIH-DK090199) 1-14. intrinsiC deFiCienCies in myoBlast proliFeration result in less diFFerentiated myoBlasts and smaller myoFiBers in iuGr Fetal sheep DT Yates, AR Macko, and SW Limesand Department of Animal Sciences, The University of Arizona, Tucson, AZ, USA Restricted skeletal muscle growth in late gestation and after birth is associated with intrauterine growth restriction (IUGR). The objective of this study was to determine whether deficient myoblast proliferation contributes to reduced skeletal muscle size in near-term IUGR fetal sheep. Compared to controls, IUGR fetuses were 67% lighter (P < 0.05) and had smaller (P < 0.05) mean semitendinosus fiber areas but similar fiber densities. Fewer (P < 0.05) nuclei stained positive for myogenin in IUGR semitendinosus and MyoD and myogenin mRNA concentrations were lower (P < 0.05) in semitendinosus muscle, which indicates less differentiated myoblasts. Furthermore, fewer (P < 0.05) Pax7-positive semitendinosus nuclei were also PCNA positive, which indicates reduced myoblast proliferation. Isolated myoblasts from both treatment groups incorporated less (P < 0.05) BrdU after being cultured in media containing IUGR fetal serum rather than control serum, which shows that IUGR serum components restrict myoblast proliferation. Moreover, IUGR myoblasts incorporated less (P < 0.05) BrdU and expressed less myoD and myogenin mRNA than control myoblasts after culture with either serum. This demonstrates that IUGR myoblasts possessed intrinsic functional deficiencies that impaired their capacity to proliferate and facilitate muscle growth. Additionally, myotubes formed in culture from IUGR myoblasts expressed less (P < 0.05) slow oxidative myosin heavy chain mRNA than myotubes from control myoblasts. Thus intrinsic deficiencies in IUGR myoblasts also alter the fiber phenotype. Together, these data begin to establish myoblast deficiencies as a cause of reduced muscle growth and impaired metabolic function in IUGR offspring. Department of Animal Sciences, North Dakota State University, Fargo, ND, and 2 University of Missouri, Columbia, MO, USA The aim of this study was to determine the effects of diet with or without Arg supplementation on production of leptin, insulin and P4. Ewes were randomly assigned to three different nutrition groups; control (C; n=24; 2.14 Mcal/kg), overfed (O; n=27; 2xC), or underfed (U; n=31; 0.6xC), and were fed a specific diet for 60 days before Arg-treatment. Estrus was synchronized using CIDRs for 14 days. After CIDR withdrawal (one day before expected estrus; d0), ewes from each nutrition group were randomly assigned to one of two treatments: Arg (L-Arg HCl, 155 µmol/ kgBW) or saline (~10 mL) administered 3 times/day from d0 through tissue collection. Blood samples were collected on d0 (estrus), 10 (mid-luteal phase), 21 (early-luteal phase) and 26 (midluteal phase) of Arg-treatment for evaluation of leptin, insulin and P4 serum concentration using radioimmunoassay or competitive chemiluminescent enzyme immunoassay. For leptin, there was a diet effect (P<0.01) for C, U, and O (5.40±0.81, 3.02±0.78 vs. 12.27±0.79 ng/ml, respectively) and a day effect (P<0.01) for d0, d10, d21 and d26 (8.23±0.57, 6.61±0.55, 6.91±0.73, vs. 5.83±0.71 ng/ml, respectively), and a diet x treatment x day interaction (P<0.02). For insulin, there was a diet effect (P<0.01) for C, U, and O (8.79±1.27, 4.18±1.13 vs. 15.49±1.21 µIU/ml, respectively). For P4, there was a diet effect (P<0.1) for C, U, and O (1.44±0.13, 1.22 ±0.11 vs. 1.57±0.12 ng/ml, respectively), a day effect (P<0.001) for d0, d10, d21 and d26 (0.22±0.04, 2.14±0.12, 1.13±0.14 vs. 2.16±0.14 ng/ml, respectively), and a diet x day interaction (P=0.05). These data reinforce the importance of dietary effects on endocrine function, and indicate that Arg supplementation does not alter serum leptin, insulin or P4 in ewes fed various nutritional planes. (Supported by USDA-AFRI grant 2011-67016-30174 to ATGB and DAR, and Hatch Project ND01748 to DAR). The etiology of pre-eclampsia (PE) is unknown; but it is accepted that normal pregnancy represents a distinctive challenge to the maternal immune system. C-reactive protein (CRP) is a component of the innate immune system; and we previously reported an association between the CRP single nucleotide polymorphism (SNP), rs1205, and severe PE in this same cohort. Our aim was to explore the effects of additional CRP variants. This study recruited 136 cases of PE and 262 matched controls from an American Indian community. The Candidate Gene-Association Resource (CARe), 50K SNP, genotyping microarray was used and is focused on the pathophysiology of cardiovascular disease. The genotypes from 10 suitable CRP SNPs were analyzed by conditional logistic regression and other methods. A replication sample of 178 cases and 427 controls of European ethnicity was also genotyped. Nominally significant differences in the distribution of discordant matched pairs were seen for rs3093068 and rs876538. Odds ratios (ORs) in G allele dominant (rs3093068) and C allele recessive models (rs876538) were significant; but with adjustment for mother's age, nulliparity and BMI the ORs attenuate to 1.78 (p=0.051, 95% CI 0.99 -3.16) for rs876538. A risk score assessing either of the above two genotypes compared with neither gives an adjusted OR of 2.14 (p=0.018, 95% CI 1. 16 -4.66) . The replication sample also demonstrated significant association of the rs876538 allele in an additive model (OR=1.55, p<0.01, 95% CI 2.16 -1.10). The CRP variants rs876538 and rs3093068 are linked with cardiovascular disease phenotypes and are associated with pre-eclampsia in this American Indian population. (Supported by NIH grant P20 RR016741) The objective of this study was to examine the effects of maternal nutrient restriction followed by realimentation on uterine artery blood flow and resistance indices during late gestation. Gestating, multiparous beef cows were randomly assigned to dietary treatments: control (CCC; 100% NRC; n = 6) from day 30 until day 254 of gestation; nutrient restriction (RCC; 60% of control; n= 5) from day 30 to day 85, then realimented to control until day 254; or nutrient restriction (RRC; 60% of control; n = 6) from day 30 to 140, then realimented to control until day 254. Hemodynamic measurements of the uterine artery ipsilateral and contralateral to the conceptus were obtained via Doppler ultrasound including uterine artery blood flow (BF), pulsatility index (PI), and resistance index (RI) on day 210, 225, and 240 of gestation. There was no treatment by day interactions (P > 0.21) for any of the variables measured. Contralateral BF was not affected (P = 0.32) by dietary treatment; however, contralateral BF was increased (P < 0.01) during late gestation. Contralateral PI and RI were not affected (P > 0.65) by dietary treatment or day (P > 0.20) of gestation. Ipsilateral and total BF were increased (P < 0.05) in RCC vs. RRC and CCC cows. Ipsilateral and total BF were increased (P < 0.01) during late gestation. Ipsilateral PI was not affected (P > 0.09) by dietary treatment or day of gestation (P > 0.22); however, ipsilateral RI was decreased (P = 0.03) in RCC and RRC vs. CCC. Uterine artery BF was increased due to maternal nutrient restriction during early gestation followed by realimentation, suggesting that placental compensation can occur and augment fetal development (Funded by USDA grant 2009-65203-05812).
2-2. two variants oF the C-reaCtive protein

2-4. nitrative stress inhiBits human ChorioniC Gonadotropin (hCG)
seCretion By plaCental CytotrophoBlasts P Díaz, CP Sibley and SL Greenwood Maternal and Fetal Health Research Centre, University of Manchester, Manchester, United Kingdom Regulation of syncytiotrophoblast (STB) renewal by cellular turnover is essential for a successful pregnancy. hCG is an important autocrine/paracrine regulator of STB turnover. Pre-eclampsia is associated with abnormal STB renewal and increased nitrative stress. Here we test the hypothesis that chronic exposure to nitrative stress regulates cytotrophoblast hCG secretion and multinucleation. Cytotrophoblasts were isolated from normal term placentas (n=7) and cultured for 66h. This preparation recreates STB formation in vivo, as mononucleate cells (15h) fuse into multinucleate syncytia (66h) concomitant with elevated secretion of hCG. Cells were untreated (control) or treated at 3, 15 and 42h with ONOO-(0.1mM) or ONOO-generator 3-morpholinosydnonimine (SIN-1; 0.5mM). At 15, 42 and 66h, culture medium was collected to measure hCG (mIU/ml/mg protein) and cells fixed for immunofluorescence with anti-desmoplakin antibody to assess multinucleation (syncytial nuclei as % of total nuclei). Cytotrophoblast multinucleation increased 10-fold (p<0.0001) and hCG secretion 20-fold (p<0.0001), between 15 and 66h. Compared to controls, SIN-1 caused a significant reduction in hCG secretion of 23, 39 and 53% (all p<0.05) at 15, 42 and 66h respectively and this was not associated with any change in multinucleation. This inhibition was not caused by cytotoxicity as total nuclei and cell protein with SIN-1 did not differ from controls. Treatment with ONOO-did not affect hCG secretion/multinucleation. Generation of ONOO-by SIN-1 significantly inhibited hCG secretion from cytotrophoblasts in vitro. K+ channels are key regulators of endocrine secretion and we have previously demonstrated that 1) intermediate conductance Ca2+-activated K+ channels (IKCa) in cytotrophoblasts are activated by peroxynitrite (ONOO-) and 2) pharmacological activation of IKCa inhibits cytotrophoblast hCG secretion in vitro. We propose that nitrative stress inhibits hCG secretion through activation of IKCa. A reduction in hCG secretion could increase susceptibility to dysregulated STB renewal in pregnancy complications associated with nitrative stress. (Supported by CONICYT-Becas Chile 72090593 and Action Medical Research). The Ritchie Centre, Monash Institute of Medical Research, 2 Department of Obstetrics and Gynecology, Monash University, Australia Antenatal stress can increase maternal plasma glucocorticoids and disturb development of the fetal hypothalamic-pituitary-adrenal axis. However, long-term effects on adrenal steroidogenesis have not been elucidated. We recently reported fetal adrenal production of dehydroepiandrosterone (DHEA) in the precocial spiny mouse (Acomys cahirinus) 1 . We therefore determined the effect of brief maternal exposure to high glucocorticoids (dexamethasone, DEX) at mid and late pregnancy on adrenal structure and cortisol/DHEA secretions in adult offspring. Pregnant spiny mice were treated for 60 h with either 125µg/kg DEX or saline s.c by osmotic minipump at day 20 (0.5 term) or 30 (0.75 term) of gestation. Protein expression of tyrosine hydroxylase (TOH), steroidogenic acute regulatory protein (StAR), 3β-hydroxysteroid dehydrogenase (3βHSD), 17-hydroxylase and 17-20lyase (p450c17), and cytochrome b5 (cytb5) were determined by immunohistochemistry in adrenal glands at 20-25 weeks of age. DHEA and cortisol were measured by radioimmunoassay. Maternal DEX at 20 days gestation did not affect adrenal structure, but expression of StAR, p450c17, and cytb5 were significantly reduced in the adult adrenal zona reticularis (ZR), with significantly greater change in male vs female offspring (p<0.05). Plasma DHEA was significantly decreased in male offspring from DEX-treated (3.8 ± 0.6 ng/ml) vs saline-treated (8.6 ± 0.8 ng/ml; p=0.001) dams; plasma cortisol was unaffected in either sex, so that the DHEA:cortisol ratio was significantly lower in males only (p<0.05). DEX treatment at 30 days of gestation had no effect on adrenal steroid enzyme expression or plasma cortisol or DHEA in either sex at 20-25 weeks of age. Brief exposure to excess glucocorticoid has a long-term impact on the ZR and adrenal steroidogenesis, affecting secretion of DHEA in male offspring, an effect produced at 0.5 but not 0.75 gestation. DHEA is important for brain development, and its suppression in adult life might contribute to the neurobehavioral pathologies that can arise after illness and stress during pregnancy. 1 Quinn et al, Endocrinology 154:1190-201.
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2-14.
In VIVo studies oF GluCose transport over the human plaCenta MCP Roland 1 , AM Holme 1 , BLorentzen 1 , TM Michelsen 1 , T Henriksen 1,2 1 Department of Obstetrics, Oslo University Hospital, Norway, 2 University of Oslo, Norway With the aim to perform studies of functional properties of placenta in the human we have established a method to obtain arterial and venous blood samples from both sides of placenta in vivo. We present our initial data by describing glucose concentrations and gradients on both sides of placenta. The study include women (n=39) with uncomplicated pregnancies undergoing planned caesarean section. College of Nursing and Professional Disciplines, 2 School of Medicine and Health Science, University of North Dakota, Grand Forks, North Dakota, USA In order to determine the feasibility of evaluating DNA methylation patterns as a contributing factor for group B streptococcus (GBS) colonization, we analyzed genome wide DNA methylation patterns in peripheral white blood cells of pregnant women with and without GBS colonization for association with immune response. Secondary analysis of DNA methylation data was completed to identify potential differences in pregnant women with and without GBS colonization in early pregnancy. A delta-beta criteria of >0.2 or <-.02 was used to determine a significant gain or loss in methylation, representing a 20% change respectively. Significance in mean methylation changes was determined at p<0.05. To identify potential for clinically relevant findings, the function of differentially methylated genes was categorized using DAVID Bioinformatics Resources v6.7. DNA methylation in >1,000 CpG sites differed by 20% or more in GBS positive versus GBS negative women. 350 CpG sites remained significantly different when a more stringent 30% change in methylation was applied. Genes with methylation changes were associated with immune response, histocompatibility, immunoglobulin, cytokine production, and the intestinal immune network for IgA production. The preliminary data suggest DNA methylation changes in genes associated with immune function may contribute to GBS colonization susceptibility. study was to determine if measured EBM protein content defines a significant degree of accumulated protein deficit over time after preterm birth. The Julie Z7 milk analyzer (Scope Electric Ltd, Germany) was used to determine EBM protein content at day of life (DOL) 10 and every 2 weeks thereafter from mothers of 10 preterm infants at 24-29 6/7 weeks gestational age at birth. The anticipated protein deficit based on milk analysis was calculated up to 12 weeks postnatal age and compared to presumed protein intake using current published mean EBM protein levels (1.4 g/dl). EBM protein content was 1.3 g/dl ± 0.04 (mean ± SD) at DOL 10 which is 7% below published estimates for EBM protein content. Assuming protein content from EBM analysis is not utilized but current published mean EBM protein levels are used for protein fortification, these infants will accumulate an average protein deficit of 25.2 grams by 12 weeks postnatal age. Without use of specific EBM protein analysis, preterm infants will accumulate significant protein deficit over time, potentially compromising growth and neurodevelopment. We speculate that individualized EBM fortification may better optimize nutrition and facilitate ideal growth and neurodevelopmental outcomes in preterm infants. A prospective, randomized, blinded and gestational age stratified trial is underway to test this hypothesis.
2-10. sexual dimorphism in the eFFeCt oF maternal adiposity on plaCental mir-210 expression S Muralimanoharan, C Guo, L Myatt, and A Maloyan Center for Pregnancy and Newborn Research, Dept of Ob/Gyn, University of Texas Health Science Center San Antonio, Texas, USA Obesity in pregnancy, which leads to developmental programming, is associated with oxidative stress and mitochondrial dysfunction in the placenta. MicroRNAs (miRs) regulate various physiological and pathological events in placenta. We demonstrated increased placental miR-210 with preeclampsia and a causative role for miR-210 in mitochondrial dysfunction in trophoblast. We tested the hypothesis that miR-210 expression is dysregulated in the placenta with increasing maternal adiposity. Placentas of both male and female fetuses were collected from healthy lean (LN: BMI 19-24.9), overweight (OW: BMI 25-29.9) and obese (OB: BMI 30-45) women (n=6 each sex/group) after C-section at term with no labor. Expression of miR-210 and its mitochondrial target genes were analyzed by RT-PCR and Western Blot. No differences in placental miR-210 expression were seen with increasing adiposity with a male fetus. However, in placentas of female fetuses miR-210 expression was upregulated 3-fold in OW and 2-fold in OB compared to LN women (p<0.05). Correspondingly miR-210 target genes, Iron Sulfur Cluster assembly proteins, NADH dehydrogenase (ubiquinone) 1α subcomplex 4 and succinate dehydrogenase complex, subunit B, were significantly reduced in female placentas with increasing maternal adiposity (p<0.05). No statistically significant changes in these genes were found in male placentas. No changes were detected in placental HIF-1α, previously shown to regulate miR-210. Rather, we found a significant increase in NFκB p65 protein expression in both male and female placentas of OW and OB women vs. LN (p<0.05). ChIP analysis confirmed miR-210 expression can be regulated by binding of NFκB p65 to miR-210 promoter. We found a 2-fold increase in p65 binding to the miR-210 promoter in female but not male placentas of OW and OB vs. LN women (p<0.05). We show a sexual dimorphism in placental miR-210 expression with increasing maternal adiposity, which may at least be partially regulated by the NFκB pathway. (Supported by NIH HD075297) 2-11. inFluenCe oF maternal adiposity on human plaCental methylome L Myatt 1 , A Parker 1 , L Liu 2 , J Ruan 2 and K Mitsuya 1 1 Center for Pregnancy and Newborn Research, Department of Ob/Gyn, University of Texas Health Science Center at San Antonio, Texas, USA, 2 Department of Computer Science, University of Texas at San Antonio, Texas, USA Over 60% of women of child bearing age in US are overweight or obese. Maternal obesity has both immediate effects on pregnancy outcome but also programs the offspring for obesity, metabolic syndrome and cardiovascular disease in adult life. The programming effect of the adverse intrauterine environment is transduced through the placenta. The interaction of environmental factors such as maternal diet with the genome may cause epigenetic changes that alter placental function. We hypothesized that increased maternal adiposity would affect the placental epigenome at the level of DNA methylation. Villous tissue was collected following cesarean section at term prior to labor from normal weight (pre-pregnant or 1st trimester BMI=23.4±2.3) and obese (BMI=34.0±2.9) women (n=10 each group). Five random samples of tissue were collected from each placenta and flash frozen. Random tissue samples were combined, genomic DNA isolated from each of the 10 placentas per group, pooled into two separate groups (normal and obese) and subjected to MeDIP-chip analysis using NimbleGen 2.1M human DNA methylation array. Initially we isolated differential methylation in the regions -500 to +500bp from transcriptional start sites. MeDIP-chip analysis identified 23,082 and 24,399 methylated regions in normal and obese placentas, respectively. We identified 21 genes where DNA methylation was significantly altered (19 increased and 2 decreased methylation) in response to maternal adiposity. The differentially methylated genes identified include those involved in placental development, cell migration, vascular remodeling, increasing BMI, lipid transport, energy metabolism, immune and/or inflammatory responses. qRT-PCR analysis demonstrated down-regulation of the differentially methylated genes that are located at the growth hormone and pregnancy-specific glycoprotein gene clusters on chromosomes 17q and19q, respectively.
2-12. Generation oF CytotrophoBlast-like Cells From human emBryoniC stem Cells in deFined media
MM Parast, Y Li, MM Zita, F Soncin, A Wakeland, LC Laurent Departments of Pathology and Reproductive Medicine, UC San Diego, La Jolla, CA, USA Human trophoblast lineage-specific differentiation is difficult to study, due to a lack of a multipotent "trophoblast stem cell" (TSC) model. First trimester human cytotrophoblast (CTB) are bipotential, with the ability to differentiate into both hCG-secreting syncytiotrophoblast (STB) and HLAGpositive extravillous trophoblast (EVT); however, access to large numbers of such cells is limited. Human embryonic stem cells (hESCs) can be differentiated into trophoblast using BMP4 in presence of feeder-conditioned media (FCM); however, these conditions are inherently inconsistent and often result in a heterogeneous population of cells. We set out to find defined media for differentiation of hESCs into bipotential CTBs. Feeder-free hESCs (WA09/H9) were cultured in StemPro+bFGF. To differentiate the cells into CTB, cells were switched to minimal media for two days, then treated with BMP4 (10 ng/ml) for an additional four days. RNA was isolated and subjected to microarray analysis, alongside RNA from first trimester CTB, placental stroma, amnion epithelial cells, JEG3, and BeWo cells. Treated hESCs were also evaluated by immunostaining for markers of pluripotency
